Literature DB >> 21039443

The relation between thyroid-stimulating hormone and measures of adiposity in patients with manifest vascular disease.

Jan Westerink1, Yolanda van der Graaf, Daniël R Faber, Frank L J Visseren.   

Abstract

BACKGROUND: Visceral adiposity is associated with cardiovascular risk factors and increased cardiovascular risk. Thyroid-stimulating hormone (TSH) levels in the normal range are associated with a higher risk of fatal coronary artery disease. We hypothesize that TSH levels in the normal range are associated with an increase in visceral adipose tissue (VAT) in patients with vascular diseases.
DESIGN: In 2419 patients with vascular diseases, visceral fat thickness was analysed with ultrasonography. The association between TSH and VAT was quantified using linear regression analysis. Results are expressed as beta (β) regression coefficients with 95% confidence intervals. Adjustments were made for age, sex, current smoking and weight. Separate analyses were performed per quartile of age.
RESULTS: β-coefficients for the relation between TSH and VAT (change per SD of 2·55 cm) was 0·085 (95% CI 0·012-0·157) in the highest quartile of age (range 67-80 years) when adjusted for age, gender and current smoking and remained statistical significant after further adjustment for weight (β 0·096 95% CI 0·034-0·157). Per SD change, the β-coefficient for TSH and VAT tissue was larger than for other measures of adiposity.
CONCLUSIONS: In conclusion, higher TSH plasma levels in the normal range are associated with more VAT in patients with manifest vascular disease above the age of 66 years. No association was found between plasma TSH levels and weight or BMI. The relation between TSH levels and VAT may provide an explanation for the increased cardiovascular risk associated with elevated TSH plasma concentrations within the normal range.
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21039443     DOI: 10.1111/j.1365-2362.2010.02391.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  8 in total

1.  Evaluation of body composition changes, epicardial adipose tissue, and serum omentin-1 levels in overt hypothyroidism.

Authors:  Ethem Turgay Cerit; Mujde Akturk; Alev E Altinova; Yusuf Tavil; Cigdem Ozkan; Cagri Yayla; Mustafa Altay; Canan Demirtas; Nuri Cakir
Journal:  Endocrine       Date:  2014-10-25       Impact factor: 3.633

2.  Changes in the before and after thyroxine treatment levels of adipose tissue, leptin, and resistin in subclinical hypothyroid patients.

Authors:  Gulhan Akbaba; Dilek Berker; Serhat Isık; Mazhar Muslum Tuna; Suha Koparal; Murat Vural; Fatma Meric Yılmaz; Canan Topcuoglu; Serdar Guler
Journal:  Wien Klin Wochenschr       Date:  2015-09-22       Impact factor: 1.704

3.  Subclinical hypothyroidism, weight change, and body composition in the elderly: the Cardiovascular Health Study.

Authors:  Margaret C Garin; Alice M Arnold; Jennifer S Lee; Russell P Tracy; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

4.  Effects of restoration of the euthyroid state on epicardial adipose tissue and carotid intima media thickness in subclinical hypothyroid patients.

Authors:  Dilek Yazıcı; Beste Özben; Ahmet Toprak; Dilek Yavuz; Hasan Aydın; Özlem Tarçın; Oğuzhan Deyneli; Sema Akalın
Journal:  Endocrine       Date:  2014-08-10       Impact factor: 3.633

5.  Epicardial Adipose Tissue Thickness in Patients With Subclinical Hypothyroidism and the Relationship Thereof With Visceral Adipose Tissue Thickness.

Authors:  Dilek Arpaci; Aysel Gurkan Tocoglu; Sabiye Yilmaz; Sumeyye Korkmaz; Hasan Ergenc; Huseyin Gunduz; Nurgul Keser; Ali Tamer
Journal:  J Clin Med Res       Date:  2016-01-26

6.  Increased waist circumference is independently associated with hypothyroidism in Mexican Americans: replicative evidence from two large, population-based studies.

Authors:  Manju Mamtani; Hemant Kulkarni; Thomas D Dyer; Laura Almasy; Michael C Mahaney; Ravindranath Duggirala; Anthony G Comuzzie; Paul B Samollow; John Blangero; Joanne E Curran
Journal:  BMC Endocr Disord       Date:  2014-06-10       Impact factor: 2.763

7.  Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism.

Authors:  Yaxin Lai; Haoyu Wang; Xinghai Xia; Zhaojun Wang; Chenling Fan; Hong Wang; Hongmei Zhang; Shuangning Ding; Weiping Teng; Zhongyan Shan
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

8.  Epicardial adipose tissue increased in patients with newly diagnosed subclinical hypothyroidism.

Authors:  Levent Korkmaz; Sinan Sahin; Ali Riza Akyuz; Murat Ziyrek; Inan Anaforoglu; Mustafa Kose; Hakan Erkan; Mustafa Tarık Ağaç; Zeydin Acar
Journal:  Med Princ Pract       Date:  2012-08-09       Impact factor: 1.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.